Literature DB >> 24974053

First experiences with the use of rivaroxaban in the treatment of heparin-induced thrombocytopenia.

H J Ng1, H Than2, E C Y Teo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24974053     DOI： 10.1016/j.thromres.2014.06.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  15 in total

Review 1.  Drug-associated thrombocytopenia.

Authors:  Tamam Bakchoul; Irene Marini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Direct oral anticoagulants in hypercoagulable states.

Authors:  Paul R Kunk; Jacqueline Brown; Melissa McShane; Surabhi Palkimas; B Gail Macik
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

3.  Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

Authors:  Hae Tha Mya; Hui Ming Tay; Shien Wen Gan; Shilpa Surendran; Shu Hui Yeang; Cynthia Ciwei Lim; HuiLin Choong; Lai Heng Lee; Heng Joo Ng
Journal:  Int J Hematol       Date:  2016-04-22       Impact factor: 2.490

Review 4.  Novel oral anticoagulants for heparin-induced thrombocytopenia.

Authors:  Jessica W Skelley; Jeffrey A Kyle; Rachel A Roberts
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

5.  Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia.

Authors:  Michelangelo Sartori; Elisabetta Favaretto; Michela Cini; Cristina Legnani; Benilde Cosmi
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 6.  Heparin-induced thrombocytopenia: research and clinical updates.

Authors:  Oluwatoyosi Onwuemene; Gowthami M Arepally
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 7.  Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.

Authors:  Phu Ngoc Tran; Minh-Ha Tran
Journal:  Clin Appl Thromb Hemost       Date:  2017-03-06       Impact factor: 2.389

8.  Rivaroxaban in treatment refractory heparin-induced thrombocytopenia.

Authors:  Joshua Misha Lewis Casan; George Grigoriadis; Noel Chan; Sanjeev Chunilal
Journal:  BMJ Case Rep       Date:  2016-08-12

9.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

10.  Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.

Authors:  Rebecca L Morgan; Vahid Ashoorion; Adam Cuker; Housne Begum; Stephanie Ross; Nina Martinez; Beng H Chong; Lori A Linkins; Theodore E Warkentin; Wojtek Wiercioch; Robby Nieuwlaat; Holger Schünemann; Nancy Santesso
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.